Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Breast cancer highlights from ASCO 2020

Erin F. Cobain • 2 Jun 2020
ASCO 2020
Breast Cancer

Erin F. Cobain, MD, of Rogel Cancer Center, Ann Arbor, MI, USA, outlines highlights in breast cancer research presented at ASCO 2020, including a discussion on the significance of local therapy for de novo metastatic breast cancer, as well as immunotherapy treatment applications for triple negative breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Erin F. Cobain

2:20
Management of patients with breast cancer during COVID-19
Erin F. Cobain • 2 Jun 2020
1:40
Unanswered questions in breast cancer
Erin F. Cobain • 2 Jun 2020
1:47
Clinical applications of circulating tumor cells
Erin F. Cobain • 2 Jun 2020
5:02
MI-ONCOSEQ: identifying pathogenic germline variants
Erin F. Cobain • 2 Jun 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals